Specialty	Neurological Surgery
Gender	Male
E-mail	yuangen.chen@mssm.edu
Education and Training	MD, Jiangxi Medical College
	Ph.D., Shanghai Medical College, Fudan University
	M.D., Jiangxi Medical College
	Fellowship, New York Medical College
	Residency, Dongxiang Hospital
	Fellowship, Oncology, New York Medical College
Awards	1996 Excellent Physician Huashan Hospital
	1995 Top Prize, The third national award of Omeprazole Research Chinese Digestive Association

Yuangen Chen, M.D, Ph.D, joined the Department of Neurosurgery in January 2005, coming from New York Medical College, Valhalla, New York, where he was a Research Associate in the Department of Microbiology and Immunology. Preceding that, he held appointments first as Assistant Professor and then Associate professor in the Division of Gastroenterology at Shanghai Medical College, Fudan University in Shanghai, China. In the Department, Dr. Chen will be supervising intraoperative monitoring of brain, spinal cord, and peripheral nervous system during neurosurgical procedures using somatosensory evoked potentials (SSEPs), brainstem auditory evoked potentials (BAEPs), motor evoked potentials (MEPs), stimulated EMG, peripheral nerve action potentials and electroencephalogram (EEG).

Education and Training	MD, Jiangxi Medical College
	Ph.D., Shanghai Medical College, Fudan University
	M.D., Jiangxi Medical College
	Fellowship, New York Medical College
	Residency, Dongxiang Hospital
	Fellowship, Oncology, New York Medical College

Specialty	Neurological Surgery

The effects of anesthetics on SSEPs and MEPs intraoperatively.

Tadi K, Ashok BT, Chen Y, Banerjee D, Wysocka-Skrzela B, Konopa J, Darzynkiewicz A, Tiwari PK. Preclinical evaluation of 1-nitroacridine derived chemotherapeutic agent that has preferential cytotoxic activity towards prostate cancer. Cancer Biol Ther 2007 Oct; 6(10): 1632-1637.

Ashok BT, Tadi K, Garikapaty VS, Chen Y, Huang Q, Banerjee D, Konopa J, Tiwari RK. Preclinical toxicological examination of a putative prostate cancer-specific 4-methyl-1-nitroacridine derivative in rodents. Anticancer 2007; 18(1): 87-94.

Tadi K, Chang Y, Ashok BT, Chen Y, Moscatello A, Schaefer SD, Schantz SP, Policastro AJ, Geliebter J, Tiwari RK. 3.3'-Diindolylmethane, a cruciferous vegetable derived synthetic anti-proferative compound in thyroid disease. Biochem Biophys Res Commun 2005 Nov 25; 337(3): 1019-1025.

Suriano R, Ghosh SK, Ashok BT, Mittelman A, Chen YG, Chen Y, Banerjee A, Tiwari RK. Differences in glycosylation patterns of heat shock protein, gp96: Implications for prostate cancer prevention. Cancer Res 2005 Jul 15; 65(14): 6466-6475.

Garikapaty VP, Ashok BT, Chen YG, Mittelman A, Iatropoulos M, Tiwari RK. Anti-carcinogenic and anti-metastatic properties of indole-3-carbinol in prostate cancer. Oncol Rep 2005 Jan; 13(1): 89-93.

Chen YG, Ashok BT, Liu X, Garikapaty VP, Mittelman A, Tiwari RK. Induction of heat shock protein gp96 by immune cytokines. Cell Stress Chaperones 2003; 8(3): 242-248.

Ashok BT, David L, Chen YG, Garikapaty VP, Chander B, Kanduc D, Mittelman A, Tiwari RK. Peptide mimotopes of oncoproteins as therapeutic agents in breast cancer. Int J Mol Med 2003; 11(4): 465-471.

Ashok BT, Chen YG, Liu X, Garikapaty VP, Seplowitz R, Tschorn J, Roy K, Mittelman A, Tiwari RK. Multiple molecular targets of indole-3-carbinol, a chemopreventive anti-estrogen in breast cancer. Eur J Cancer Prev 2002 Aug; 11(Suppl 2:S): 86-93.

Ashok BT, Chen YG, Liu X, Bradlow HL, Mittelman A, Tiwari RK. Abrogation of estrogen-mediated cellular and biochemical effects by indole-3-carbinol. Nutr Cancer 2001; 41(1-2): 180-187.

Wang L, Lu W, Chen YG, Zhou XM, Gu JR. Comparison of gene expression between normal colon mucosa and colon carcinoma by means of messenger RNA differential display. World J Gastroenterol 1999 Dec; 5(6): 533-534.